Exhibit 99.1

DATE: February 17, 2005

FOR IMMEDIATE RELEASE

AMERICAN MEDICAL SYSTEMS REPORTS RECORD
$209 MILLION SALES FOR 2004

Women’s Health Tops 40% Growth in 2004;
TherMatrx Acquisition Beats Guidance

MINNEAPOLIS, February 17, 2005 — American Medical Systems Holdings, Inc. (NASDAQ: AMMD) reported record sales of $60.0 million for the fourth quarter of 2004, a 27.3 percent increase over sales of $47.2 million in the comparable quarter of 2003 (with 1.7 percentage points of the increase coming from currency exchange rate changes).

     The Company reported net income of $6.7 million, or $0.19 per share, including the $4.5 million effect of an investment write-off (with no associated tax benefit) related to InjecTx, a company focused on the development of ethanol ablation systems for prostate treatment. Fourth quarter net earnings also included the benefit of adjusting the Company’s 2004 tax rate down by one percentage point to 35.5 percent. The prior year’s fourth quarter earnings were reported at $10.3 million, or $0.30 per share, including a $2.0 million non-recurring warranty reserve benefit net of tax. All per share amounts reported are prior to the effect of the proposed 2-for-1 stock split announced by the Company on January 10, 2005 and subject to shareholder approval of an increase in the number of authorized shares of common stock from 75 million to 200 million at a special meeting to be held on March 4, 2005.

     Net income for the quarter, excluding the impact of the investment write-off and the effect of the tax rate change on the prior three quarters’ earnings, was a record $10.8 million, or $0.30 per share. Net income for fourth quarter 2003, adjusted for the warranty reserve benefit, was $8.4 million, or $0.24 per share. Net income growth, excluding the impact of these non-recurring items for both 2004 and 2003, was 29.5 percent. A reconciliation of GAAP earnings to these adjusted results is included in the attached financial tables.

     Sales for the full year 2004 were $208.8 million, up 24.1 percent from sales of $168.3 million during 2003 (with 2.1 percentage points of the increase coming from currency exchange rate changes). The year’s revenue includes $10.5 million from the Company’s first two quarters’ sales from the acquisition of TherMatrx, Inc.

     The net loss as reported for the year 2004 was $3.1 million, or $0.09 per share. This reported net loss includes the impacts of the $4.5 million InjecTx write-off and the third quarter impact of a $35.0 million in-process research and development (IPR&D) charge related to the TherMatrx acquisition. Reported net income for 2003 was $29.1 million, or $0.85 per share, including the warranty reserve benefit previously described and a $1.1 million benefit from prior years’ tax credits. Excluding these non-recurring items in both years, net income for 2004 was $36.4 million, or $1.03 per share, up 39.9 percent from $26.0 million, or $0.76 per share, in 2003. A reconciliation of GAAP earnings to these adjusted year-to-date results is included in the attached financial tables.

 


The following information was filed by American Medical Systems Holdings Inc on Thursday, February 17, 2005 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate American Medical Systems Holdings Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Medical Systems Holdings Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account